Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients

NCT00239018 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

De Novo Kidney Transplantation

Interventions

DRUG: Enteric-Coated Mycophenolate Sodium (EC-MPS)

Sponsor

Novartis